share_log

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4:持股變動聲明-高管 Kupiec James William
美股SEC公告 ·  09/09 17:46

Moomoo AI 已提取核心訊息

James William Kupiec, the Chief Medical Officer of Cassava Sciences Inc. (ticker: SAVA.US), was involved in a transaction with the company's stock on September 6, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. As a result, the impact of this event on Kupiec's holdings and the overall market perception of Cassava Sciences remains unclear.
James William Kupiec, the Chief Medical Officer of Cassava Sciences Inc. (ticker: SAVA.US), was involved in a transaction with the company's stock on September 6, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. As a result, the impact of this event on Kupiec's holdings and the overall market perception of Cassava Sciences remains unclear.
Cassava Sciences Inc.(逐筆明細:SAVA.US)首席醫療官詹姆士·威廉姆·庫皮克(James William Kupiec)在2024年9月6日參與了一項與公司股票有關的交易。具體交易細節,如操作類型、狀態、股份數量、股份性質、交易價格和總價值,在公告中未披露。因此,這一事件對庫皮克的持股情況以及市場對Cassava Sciences的整體看法的影響尚不清楚。
Cassava Sciences Inc.(逐筆明細:SAVA.US)首席醫療官詹姆士·威廉姆·庫皮克(James William Kupiec)在2024年9月6日參與了一項與公司股票有關的交易。具體交易細節,如操作類型、狀態、股份數量、股份性質、交易價格和總價值,在公告中未披露。因此,這一事件對庫皮克的持股情況以及市場對Cassava Sciences的整體看法的影響尚不清楚。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息